ACCELLIX
Accelix is a biotechnology company that helps cell and gene therapy companies to meet their key product QC requirements. It provides an instrument and a room temperature stable cartridge to gather multi-parameter results. The company was founded in 2007 and headquartered in Yerushalayim, Israel.
ACCELLIX
Industry:
Biotechnology Data Center Automation
Founded:
2013-06-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.accellix.com
Total Employee:
11+
Status:
Active
Contact:
+972 2-674-4422
Email Addresses:
[email protected]
Total Funding:
19.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content Nginx Euro Microsoft Exchange Online Amazon Office 365 Mail
Similar Organizations
Cagen Bio
Cagen Bio is a vitro diagnostic reagents developer.
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
BroadOak Capital Partners
BroadOak Capital Partners investment in Series E - Accellix
bioMerieux
bioMerieux investment in Series D - Accellix
Official Site Inspections
http://www.accellix.com Semrush global rank: 5.68 M Semrush visits lastest month: 1.48 K
- Host name: niau.deliciousdesign.com
- IP address: 165.232.146.198
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Accellix"
About Accellix’s Next-Generation Flow Cytometry Technology
The Accellix Mission. At Accellix, our mission is to transform the status quo for quality control in the cell and gene therapy industry. We seek to establish ourselves as the New Gold Standard …See details»
A Revolutionary Approach to QC in Cell and Gene …
The Accellix Mission. At Accellix, our mission is to transform the status quo for quality control in the cell and gene therapy industry. We seek to establish ourselves as the New Gold Standard for QC through our Accellix Platform, a …See details»
Accellix - Crunchbase Company Profile & Funding
Organization. Accellix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Quality control assays used for routine verification of the Accellix instrument's performance, …See details»
Accellix - LinkedIn
Accellix aims to enable cell and gene therapy companies to meet their key product QC requirements by providing fast and actionable multi-parameter results using the Accellix instrument and a room ...See details»
Accellix Company Profile 2024: Valuation, Funding & Investors
Accellix General Information Description. Operator of a biotechnological instrument and system company designed to provide quick and accurate flow cytometry results. The company's …See details»
ACCELLIX | Pioneering Diagnostics - bioMérieux Website
Cell and Gene Therapy Quality Control is critical. It doesn’t have to be difficult. Stringent process controls are needed to monitor critical parameters throughout the cell therapy manufacturing process, and these laborious tests are …See details»
Accellix Company Profile - Office Locations, Competitors ... - Craft
Accellix (formerly known as LeukoDx) is a biotechnology company developing a platform to enable its customers in the field of cell and gene therapy to meet their quality control …See details»
Accellix - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Accellix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... including Chairman and Chief Executive Officer Nir …See details»
Accellix Appoints Greg Hamilton as Chief Executive Officer as …
Sep 23, 2024 Accellix is a biotechnology company dedicated to developing and commercializing the Accellix Platform to enable its customers in the field of cell and gene therapy to meet their …See details»
Accellix - Funding, Financials, Valuation & Investors - Crunchbase
Accellix is an assay delivery platform. How much funding has this organization raised over time? ShowSee details»
Accellix Expands Leadership Team and Announces Name Change
Jul 25, 2019 SAN JOSE, Calif. & JERUSALEM — LeukoDx, Inc. (“the Company”), is pleased to announce the official name change to Accellix, Inc. (“Accellix”) effective immediately. “The cell …See details»
Accellix, Inc Expands Leadership Team and Announces Name …
Jul 25, 2019 Accellix empowers its customers by migrating their existing cell assays to the Accellix platform. The Accellix is a benchtop cytometer operating and reading capillary …See details»
Cell Therapy QC Company, Accellix, Raised $9.5 Million in Series D ...
Oct 27, 2020 Jerusalem based, Accellix, the Cell Therapy QC company, had a Series D financing round of $9.5 million led by bioMérieux, a world leader in the field of in vitro …See details»
Accellix Raises $10 Million From BroadOak Capital Partners
Dec 13, 2021 Accellix is a biotechnology company dedicated to developing and commercializing the Accellix Platform to enable its customers in the field of cell and gene therapy to meet their …See details»
Accellix Appoints Greg Hamilton as Chief Executive Officer as …
Sep 23, 2024 SAN JOSE, Calif. & JERUSALEM — Accellix, Inc., the leading sample to answer flow cytometry GMP platform company, is pleased to announce the appointment of Greg …See details»
Accellix, Inc. Announces Their Next Generation Accellix Instrument …
Apr 29, 2020 About Accellix: Accellix is a biotechnology company dedicated to developing and commercializing the Accellix platform to enable its customers in the field of cell and gene …See details»
Accellix, the Cell Therapy QC Company Raises $9.5 Million Series D ...
Jun 11, 2020 SAN JOSE, Calif. & JERUSALEM--(BUSINESS WIRE)--Today Accellix, the Cell Therapy QC company, announced a Series D financing round of $9.5 million led by …See details»
Accellix Platform Overview - YouTube
Learn about Accellix, the only cell phenotyping platform that brings automated sample preparation, flow cytometry, and data analysis into the GMP manufacturi...See details»
News - Accellix, Inc.
May 5, 2021 Accellix will use the investment to expand its commercial resources and infrastructure in support of its cell therapy customers SAN JOSE, Calif. & BETHESDA, Md. — …See details»